CRMAX
Price
$10.19
Change
-$0.04 (-0.39%)
Updated
Aug 8 closing price
Net Assets
129.8M
FSMDX
Price
$35.65
Change
-$0.10 (-0.28%)
Updated
Aug 8 closing price
Net Assets
43.39B
Interact to see
Advertisement

CRMAX vs FSMDX

Header iconCRMAX vs FSMDX Comparison
Open Charts CRMAX vs FSMDXBanner chart's image
CRM Small/Mid Cap Value I
Price$10.19
Change-$0.04 (-0.39%)
VolumeN/A
Net Assets129.8M
Fidelity Mid Cap Index
Price$35.65
Change-$0.10 (-0.28%)
VolumeN/A
Net Assets43.39B
CRMAX vs FSMDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CRMAX vs. FSMDX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMAX is a Hold and FSMDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 43.4B vs. CRMAX (130M). FSMDX pays higher dividends than CRMAX: FSMDX (1.29) vs CRMAX (0.29). CRMAX was incepted earlier than FSMDX: CRMAX (21 years) vs FSMDX (14 years). CRMAX (1.21) is less costly to investors than FSMDX (0.03). CRMAX is a more actively managed with annual turnover of: 72.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than CRMAX: FSMDX (0) vs CRMAX (2500). FSMDX annual gain was more profitable for investors over the last year : 14.07 vs. CRMAX (-9.39). FSMDX return over 5 years is better than : 65.33 vs. CRMAX (-3.01).
CRMAXFSMDXCRMAX / FSMDX
Total Expense Ratio1.210.034,840%
Annual Report Gross Expense Ratio1.210.034,840%
Fund Existence21 years14 years-
Gain YTD-5.5406.120-91%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets130M43.4B0%
Annual Yield % from dividends0.291.2923%
Returns for 1 year-9.3914.07-67%
Returns for 3 years-2.1235.77-6%
Returns for 5 years-3.0165.33-5%
Returns for 10 years-28.06121.75-23%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICCC6.660.52
+8.47%
ImmuCell Corp
CHSCN25.40-0.02
-0.08%
CHS
DYN11.16-0.03
-0.27%
Dyne Therapeutics
AXTA28.39-0.08
-0.28%
Axalta Coating Systems Ltd
LE12.96-0.42
-3.14%
Lands' End